High risk of relapse with high mutation burden at day 21 post-transplant can be overcome by chronic GVHD in patients with AML

BONE MARROW TRANSPLANTATION(2018)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要